Latest Capital Markets News

QPM Energy has secured Northern Australia Infrastructure Facility approval to enter due diligence for financing its 112MW Isaac Power Station, marking a key step toward final investment decision by late 2025.

Horizon Gold has completed a major drilling campaign at its Gum Creek Gold Project, delivering high-grade gold intercepts and advancing its feasibility study on track for early 2026. A $12 million capital raise post-quarter end aims to fund further exploration and project development.

Tamboran Resources appoints Chairman Dick Stoneburner as interim CEO following Joel Riddle’s departure, while adding two seasoned energy executives to its board as it advances gas production plans in the Beetaloo Basin.

Nimy Resources reports impressive high-grade gallium assays from its Block 3 East drilling campaign, advancing towards a maiden JORC-compliant resource at the Mons Project. The company also strengthens its metallurgical research partnerships and secures fresh capital to fuel ongoing exploration.

Echo IQ has secured a strategic collaboration with the Mayo Clinic Platform and raised $17.3 million, advancing its AI-driven cardiology tools towards FDA clearance and US commercial scale.

DY6 Metals has clarified its compliance with ASX continuous disclosure rules following a material capital raising and CEO appointment, confirming timely and confidential handling of sensitive information.

Income Asset Management Group Limited delivered its strongest quarter ever in Q4 FY2025, reporting record revenue and robust growth in funds under advice alongside positive operating cash flow.

NOVONIX has entered a multi-tranche funding agreement with Yorkville Advisors to raise up to US$100 million through convertible debentures, supporting its Riverside facility build-out and commercial production ramp-up.

Macquarie Group Limited reported a 5% increase in FY25 profit to A$3.715 billion, declaring a higher dividend and announcing a key CFO transition. The group also outlined a strategic divestment and cautious outlook for FY26.

Agrimin Limited progresses its Mackay Potash Project with ongoing strategic review and strong stakeholder backing, while securing $2.5 million through equity placement and completing the Tali Resources IPO.

Amplia Therapeutics has successfully raised A$25 million through an institutional placement and launched a A$2.5 million Share Purchase Plan to fund pivotal clinical trials of its lead drug narmafotinib. The capital injection positions the company to advance key pancreatic and ovarian cancer studies into 2027.

IperionX has successfully commissioned its Virginia titanium manufacturing campus, secured a substantial U.S. Department of Defense contract, and raised $46 million to fast-track production expansion through 2030.